Lisa A. Lacasse/X
Jun 27, 2025, 06:39
Lisa A. Lacasse: The Cancer Drug Parity Act Would Equalize Out-of-pocket Costs for Cancer Drugs
American Cancer Society Cancer Action Network (ACS CAN) shared a post on LinkedIn:
“This week, the U.S. House of Representatives introduced the Cancer Drug Parity Act, which seeks to lower out-of-pocket costs for all cancer treatments, regardless of how they are administered.
‘Disparities in out-of-pocket costs for oral cancer treatments can impact patient and physician decision-making and can lead to patients forgoing the best treatment for their disease. Many patients prefer, when appropriate, chemotherapies that are available in pill form because it is easier to administer and can allow them to have a better quality of life. The Cancer Drug Parity Act would equalize out-of-pocket costs for cancer drugs, whether they’re taken orally or delivered intravenously,’ said Lisa A. Lacasse, President of ACS CAN.
ACS CAN urges Congress to swiftly pass this bipartisan legislation to reduce barriers to cancer care for patients across the country.”
More posts featuring ACS CAN on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 27, 2025, 06:17
Jun 27, 2025, 06:06
Jun 27, 2025, 05:56
Jun 27, 2025, 05:35